Summary Description: BPC-157 and TB-500 is an investigational blend of two well-studied peptides known for their regenerative and cytoprotective properties. BPC-157, derived from a gastric protein, is recognized for promoting angiogenesis, cellular migration, and tissue healing across various organ systems
1,2. TB-500, a synthetic fragment of thymosin beta-4, enhances cellular motility, reduces inflammation, and stimulates new blood vessel formation
3,4. Together, this synergistic blend is being explored in preclinical research for its ability to accelerate wound healing, mitigate inflammation, and enhance recovery in models of soft tissue injury, nerve damage, and musculoskeletal trauma. While individually effective, the co-administration of BPC-157 and TB-500 may produce more robust regenerative outcomes by targeting both the structural and signaling components of tissue repair.
Products will arrive in a lyophilized (powder) form for maximum stability